-
Purpose(Empty Backbone) Allows expression of shRNA from U6 promoter and a rescue cDNA from a doxycyclin inducible promoter in the same plasmid. Contains puromycin resistance gene
-
Depositing Lab
-
Publication
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 23105 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepUHD-P3
- Backbone size (bp) 5669
-
Modifications to backboneSee associated publication for details of plasmid construction.
-
Vector typeMammalian Expression, RNAi
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameNone
- Promoter TRE for cDNA; U6 for shRNA
-
Tag
/ Fusion Protein
- Flag (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site see paper (not destroyed)
- 3′ cloning site see paper (not destroyed)
- 5′ sequencing primer LNCX
- 3′ sequencing primer EBV-rev (Common Sequencing Primers)
Resource Information
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
This vector is designed for dual expression of a shRNA and the respective rescue cDNA to allow a one-step validation of shRNAs and generation of stable shRNA-expressing cells. The shRNA is expressed under the control of a mouse U6 RNA promoter, while the rescue cDNA is expressed under the control of a doxycycline-inducible promoter. The effects of gene knockdown by the shRNA are effectively under conditional control as cDNA expression can be regulated by the inducible promoter.
The shRNA sequence must be cloned into this plasmid using BbsI and XbaI sites BEFORE cloning the cDNA, otherwise the NcoI, XhoI, EcoRI and BamHI sites will not be unique for subcloning of the cDNA. Note that the cloning of the shRNA sequence into the plasmid will replace the EGFP in this plasmid.
See pKAR1 (Addgene plasmid 23104; http://www.addgene.org/23104/) for sequence and map of this vector before the puromycin resistance gene was cloned in.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pKAR1/Pur was a gift from Randy Poon (Addgene plasmid # 23105 ; http://n2t.net/addgene:23105 ; RRID:Addgene_23105) -
For your References section:
An inducible system for expression and validation of the specificity of short hairpin RNA in mammalian cells. Ma HT, On KF, Tsang YH, Poon RY. Nucleic Acids Res. 2007 . 35(4):e22. 10.1093/nar/gkl1109 PubMed 17234679